Using nutrition, exercise and his knowledge of supplementation he has helped a number of injured patients return to their activities in a significantly reduced time. Pre-operative programs help surgical outcome and reduce the down time for both sports and non-sports related injuries. Many natural products are available to accomplish these goals.

Dr. Mark Gordon has been recognized as a leader in the area of Anti Aging Medicine and holds Associate Clinical Professorships at USC and UCLA.

Dr. Gordon has recently been reappointed as Medical Director for CBS Studios, Medical Consultant to HBO and FX. In these positions he is available for consultation on areas of Preventive, Anti-Aging and Alternative Medicine. He writes articles on nutritional supplementation and hormonal replacement some of which have been published in Max Muscle and Planet Muscle. Dr. Gordon is owner and Medical Director of Millennium Health Centers-Medicine for the 21st century.

Read More

As melanoma rates and diagnosis continue to rise, early detection (before the disease spreads to the lymph nodes) is critical for survival. In the January-February 2009 issue of Dermatology Nursing, Arlene Vickers describes how dermatology nurses can use evidence-based practice (EBP) to develop their own skin cancer screening guidelines.

Vickers recommends obtaining best practices by using several resources:

- Conducting systematic reviews through journal databases to answer specific clinical questions
- Evaluating existing skin cancer screening guidelines (many are posted on the National Guideline Clearinghouse Web site, http://www.guideline.gov)
- Keeping up with current research studies
- Looking to professional organizations for information and guidelines

Read More

As a pioneer in the field of Anti-Aging Mecidine, Ronald Rothenberg, MD, was one of the first physicians to be recognized for his expertise to become fully board certified in the specialty. Dr. Rothenberg founded the Calfornia HealthSpan Institute in Cencinitas, Calfironia in 1997 with a commitment to transforming our understanding of and finding treatment for aging as a disease. Dr. Rothenberg is dedicated to the belief that the process of aging can be slowed, stopped, or even reserved through existing medical and scientific interventions.

Challenging traditional medicine’s approach to treating the symptoms of aging, California HealthSpan’s mission is to create a paradigm shift in the way we view medicine: treat the cause. He received his MD from Columbia University, College of Physicians and Surgeons in 1970. Dr. Rothenberg performed his residency at Los Angeles County-USC Medical Center and is also board certified in Emergency Medicine. He received academic appointment to the USCD School of Medicine Clinical Faculty in 1997 and was promoted to full Clinical Professor of Preventive and Family Medicine in 1989. In addition to his work in the field of Anti-Aging Medicine, Dr. Rothenberg is an Attending Physician and Director of Medical Education at Scripps Memorial Hospital in Encinitas, California. Dr. Rothenberg travels extensively to lecture on a variety of topics, which include Anti-Aging Medicine and Emergency Medicine and is the author of Forever Ageless. He has recently been featured in the University of California MD TV series in the shows on Anti-Aging Medicine.

Read More

New research suggests that blocking the activity of a protein in the blood could offer powerful protection against some skin cancers.

In the study, normal mice and mice that had a genetically engineered protein deficiency were exposed to almost a year of ultraviolet light that mimics chronic sun exposure. The mice that lacked the protein developed fewer, smaller, less aggressive and less vascular skin cancer tumors than did the normal mice.

Because a low-dose drug that blocks the protein’s activity in the blood is currently under investigation by a Pennsylvania pharmaceutical company, the researchers hope that someday, a simple pill might help prevent or treat nonmelanoma skin cancer in people at highest risk for the disease.

The HTA (Human Tissue Authority) is announcing new rules for bone and skin products to protect patients from diseases such as HIV, Hepatitis C and CJD. The HTA already regulates the use of tissue containing cells to treat patients. The new rules will apply to material from humans that does not contain any cells.

The new rules mainly apply to two types of acellular product:

- products from bone used in orthopaedic surgery, such as hip or knee operations, or dentistry

- products from skin used to promote wound healing after injury or burns

The new rules will only affect those companies who import or store acellular products prior to distribution to end users. Companies must apply to the HTA for a licence by 6 April 2009 although earlier applications are welcomed. The HTA policy on acellular material has been revised in light of adverse events happening in other parts of Europe and on the advice of the European Commission.

Read More